Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

28.30
-0.0500-0.18%
Post-market: 28.300.00000.00%16:01 EDT
Volume:3.14M
Turnover:89.10M
Market Cap:7.98B
PE:76.08
High:28.97
Open:28.72
Low:28.07
Close:28.35
52wk High:33.66
52wk Low:14.19
Shares:282.15M
Float Shares:116.00M
Volume Ratio:0.88
T/O Rate:2.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3720
EPS(LYR):-3.2200
ROE:20.13%
ROA:8.77%
PB:13.49
PE(LYR):-8.79

Loading ...

Nov 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 29, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 07, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Sep 18, 2019

Major Issues Report

Current report, items 2.05 and 2.06
Sep 10, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 23, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jun 13, 2019

Major Issues Report

Current report, items 5.02, 5.07, and 9.01
May 03, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 07, 2018

[Supp]Public Prospectus

Jul 13, 2018

Correspondence

Mar 23, 2018

[Supp]Public Prospectus